A detailed history of Sienna Gestion transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sienna Gestion holds 60,650 shares of GILD stock, worth $4.04 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
60,650
Holding current value
$4.04 Million
% of portfolio
0.4%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$71.58 - $87.29 $4.34 Million - $5.29 Million
60,650 New
60,650 $4.44 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sienna Gestion Portfolio

Follow Sienna Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sienna Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Sienna Gestion with notifications on news.